Regulations.gov document
Memorandum of Meeting Minutes between FDA CDER and BASF regarding Octyl Triazone and…
Other · FDA-2003-N-0196 · posted Jun 15, 2015
Key facts
| Document ID | FDA-2003-N-0196-0094 |
|---|---|
| Title | Memorandum of Meeting Minutes between FDA CDER and BASF regarding Octyl Triazone and Bemotrizinol March 19, 2015 |
| Document type | Other |
| Subtype | Memorandum |
| Agency | FDA |
| Docket | FDA-2003-N-0196 |
| Posted | Jun 15, 2015 |
| Comment period opens | Jun 15, 2015 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: